Valuation: ChronoScale Holdings Corporation

Market Cap 264.06Cr 231.61Cr 213.83Cr 197.6Cr 374.52Cr 25TCr 382.02Cr 2.57TCr 998.79Cr 12TCr 991.64Cr 969.9Cr 43TCr P/E 2024 *
-
P/E 2025 -
Enterprise Value 285.82Cr 250.69Cr 231.44Cr 213.87Cr 405.37Cr 27TCr 413.49Cr 2.78TCr 1.08TCr 13TCr 1.07TCr 1.05TCr 46TCr EV / Sales 2024 *
-
EV / Sales 2025 2.71x
Free-Float
2.43%
Yield 2024 *
-
Yield 2025 -
1 day-4.00%
1 week-0.68%
Current month-21.15%
1 month-7.25%
3 months+100.69%
6 months+113.92%
Current year+102.78%
1 week 16.32
Extreme 16.32
19.7
1 month 15.53
Extreme 15.5337
28.2
Current year 6.93
Extreme 6.93
28.2
1 year 2.91
Extreme 2.9078
28.2
3 years 2.73
Extreme 2.73
46.93
5 years 2.73
Extreme 2.73
81.15
10 years 2.73
Extreme 2.73
1,527.98
Date Insider Type Main position Quantity % Market Cap.
29/06Free

Director

2,00,000 0.1377%
14/05Free

Director

1,09,357 1.5345%
14/05Free

Director

2,00,000 2.8063%
Change 5-day change 1-year change 3-year change Capi.($)
-4.00%-0.68%+406.36%-13.48% 251.98Cr
-1.26%-0.62%+19.70%-0.70% 19TCr
-2.86%+3.16%-21.28%+25.30% 15TCr
-1.76%-1.52%-4.94%-18.15% 14TCr
-1.08%+4.06%-56.24%-14.30% 6.73TCr
-1.24%+1.79%+22.58%+3.74% 5.46TCr
-2.84%-0.67%-26.99%-30.92% 4.49TCr
-1.58%-3.24%+6.66%+10.32% 3.7TCr
-1.81%-2.64%+5.85%+39.36% 3.68TCr
-6.33%+2.36%-19.78%-4.62% 3.17TCr
Average -2.48%-0.59%+33.19%-0.35% 7.56TCr
Weighted average by Cap. -2.01%+2.40%-4.00%+0.93%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Logo ChronoScale Holdings Corporation
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.
Employees
-
Date Price Change Volume
08/26/08 $18.02 +2.85% 2,31,242
07/26/07 $17.52 -4.00% 5,01,355
06/26/06 $18.25 +10.67% 4,14,979
02/26/02 $16.49 -6.52% 6,70,303
01/26/01 $17.64 -20.61% 8,07,653
  1. Stock Market
  2. Stocks
  3. CHRN Stock